{
"NDC": {
"NDCCode": "17312-478-14",
"PackageDescription": "1 BOTTLE in 1 PACKAGE (17312-478-14) / 70 TABLET in 1 BOTTLE",
"NDC11Code": "17312-0478-14",
"ProductNDC": "17312-478",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Natural Eyes Floaters Relief",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Chelidonium, Euphrasia, Kali Sulph, Natrum Muriaticum, Phosphorus, Physostigma, Sepia, Silicea",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20250428",
"EndMarketingDate": null,
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"ApplicationNumber": null,
"LabelerName": "TRP Company",
"SubstanceName": "CHELIDONIUM MAJUS; EUPHRASIA STRICTA; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE",
"StrengthNumber": "6; 6; 12; 12; 10; 7; 12; 10",
"StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
"Pharm_Classes": "Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250428",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}